.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Colorcon
Cipla
Harvard Business School
US Army
Julphar
Johnson and Johnson
Novartis
Cerilliant
Farmers Insurance

Generated: June 26, 2017

DrugPatentWatch Database Preview

Famotidine; ibuprofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for famotidine; ibuprofen and what is the scope of famotidine; ibuprofen patent protection?

Famotidine; ibuprofen
is the generic ingredient in one branded drug marketed by Horizon Pharma and is included in one NDA. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Famotidine; ibuprofen has twenty-two patent family members in fourteen countries.

There are eighteen drug master file entries for famotidine; ibuprofen. One supplier is listed for this compound.

Summary for Generic Name: famotidine; ibuprofen

Tradenames:1
Patents:6
Applicants:1
NDAs:1
Drug Master File Entries: see list18
Suppliers / Packagers: see list1
Clinical Trials: see list541
Drug Prices:see low prices
DailyMed Link:famotidine; ibuprofen at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Horizon Pharma
DUEXIS
famotidine; ibuprofen
TABLET;ORAL022519-001Apr 23, 2011RXYesYes8,449,910► SubscribeY ► Subscribe
Horizon Pharma
DUEXIS
famotidine; ibuprofen
TABLET;ORAL022519-001Apr 23, 2011RXYesYes8,067,033► SubscribeY ► Subscribe
Horizon Pharma
DUEXIS
famotidine; ibuprofen
TABLET;ORAL022519-001Apr 23, 2011RXYesYes8,067,451► SubscribeY ► Subscribe
Horizon Pharma
DUEXIS
famotidine; ibuprofen
TABLET;ORAL022519-001Apr 23, 2011RXYesYes8,318,202► SubscribeY ► Subscribe
Horizon Pharma
DUEXIS
famotidine; ibuprofen
TABLET;ORAL022519-001Apr 23, 2011RXYesYes8,309,127► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: famotidine; ibuprofen

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2008011426► Subscribe
Israel196425► Subscribe
New Zealand565846► Subscribe
Israel188732► Subscribe
Australia2007275360► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Accenture
AstraZeneca
Healthtrust
Argus Health
Johnson and Johnson
Merck
Chubb
UBS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot